Antitumor effect of a pyrazolone-based-complex [Cu(PMPP-SAL)(EtOH)] against murine melanoma B16 cell in vitro and in vivo

Pyrazolone-based derivative metal complexes were reported to have cytotoxicity in some tumor cells. In this study, the antitumor effect of [Cu(PMPP-SAL)(EtOH)] (PMPP-SAL = -(1-phenyl-3-methyl-4-propenylidene-5-pyrazolone)- salicylidene hydrazide anion) in murine melanoma B16 cells and was investigat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Acta pharmaceutica (Zagreb, Croatia) Ročník 70; číslo 4; s. 561 - 575
Hlavní autoři: Abula, Ayipairi, Zhao, Jing, Xu, Guancheng, Li, Yijie, Sun, Surong
Médium: Journal Article
Jazyk:angličtina
Vydáno: Poland Sciendo 01.12.2020
De Gruyter Brill Sp. z o.o., Paradigm Publishing Services
Témata:
Angiogenesis
Angiogenesis Inhibitors - pharmacology
Animals
Antigens, CD34 - biosynthesis
Antineoplastic Agents - pharmacology
Antitumor activity
Apoptosis
Cadmium
Cell cycle
Cell Survival - drug effects
Cisplatin
Cisplatin - pharmacology
Copper
Cu(PMPP-SAL)(EtOH)
Cytotoxicity
Drug Screening Assays, Antitumor
Fibroblast growth factor 2
G1 phase
Growth factors
malignant melanoma
Melanoma
Melanoma, Experimental - drug therapy
Mice
Mice, Inbred C57BL
Pyrazolones - pharmacology
Solid tumors
Tumor cells
tumor microangiogenesis
Vascular endothelial growth factor
Vascular Endothelial Growth Factor A - biosynthesis
Xenograft Model Antitumor Assays
tumor microangiogenesis
apoptosis
malignant melanoma
Cu(PMPP-SAL)(EtOH)
ISSN:1846-9558, 1330-0075, 1846-9558
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Pyrazolone-based derivative metal complexes were reported to have cytotoxicity in some tumor cells. In this study, the antitumor effect of [Cu(PMPP-SAL)(EtOH)] (PMPP-SAL = -(1-phenyl-3-methyl-4-propenylidene-5-pyrazolone)- salicylidene hydrazide anion) in murine melanoma B16 cells and was investigated. The results showed that [Cu(PMPP-SAL)(EtOH)] inhibited the survival of B16 cells , and the value was superior to cisplatin (DDP) ( < 0.001). B16 cell apoptosis was significantly higher in comparison to the control group (DMSO) ( < 0.01), and cell cycle arrest occurred at the G0/G1 phase. When challenged C57 BL/6J mice were treated with [Cu(PMPPSAL)(EtOH)], a smaller volume of B16 solid tumors were reported than the control group ( < 0.01), with lower positive expression indices of CD 34, vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) ( < 0.01). Moreover, the tumor growth was suppressed in mice due to the induction of apoptosis, as detected by the TUNEL assay ( < 0.001). In summary, [Cu(PMPP-SAL)(EtOH)] effectively inhibited the growth of B16 cells and due to the induction of apoptosis and the inhibition of intra-tumoral angiogenesis, demonstrating its therapeutic potential in melanoma treatment.
AbstractList Pyrazolone-based derivative metal complexes were reported to have cytotoxicity in some tumor cells. In this study, the antitumor effect of [Cu(PMPP-SAL)(EtOH)] (PMPP-SAL = N-(1-phenyl-3-methyl-4-propenylidene-5-pyrazolone)- salicylidene hydrazide anion) in murine melanoma B16 cells in vitro and in vivo was investigated. The results showed that [Cu(PMPP-SAL)(EtOH)] inhibited the survival of B16 cells in vitro, and the IC50 value was superior to cisplatin (DDP) (p < 0.001). B16 cell apoptosis was significantly higher in comparison to the control group (DMSO) (p < 0.01), and cell cycle arrest occurred at the G0/G1 phase. When challenged C57 BL/6J mice were treated with [Cu(PMPPSAL)(EtOH)], a smaller volume of B16 solid tumors were reported than the control group (p < 0.01), with lower positive expression indices of CD 34, vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) (p < 0.01). Moreover, the tumor growth was suppressed in mice due to the induction of apoptosis, as detected by the TUNEL assay (p < 0.001). In summary, [Cu(PMPP-SAL)(EtOH)] effectively inhibited the growth of B16 cells in vitro and in vivo due to the induction of apoptosis and the inhibition of intra-tumoral angiogenesis, demonstrating its therapeutic potential in melanoma treatment.
Pyrazolone-based derivative metal complexes were reported to have cytotoxicity in some tumor cells. In this study, the antitumor effect of [Cu(PMPP-SAL)(EtOH)] (PMPP-SAL = -(1-phenyl-3-methyl-4-propenylidene-5-pyrazolone)- salicylidene hydrazide anion) in murine melanoma B16 cells and was investigated. The results showed that [Cu(PMPP-SAL)(EtOH)] inhibited the survival of B16 cells , and the value was superior to cisplatin (DDP) ( < 0.001). B16 cell apoptosis was significantly higher in comparison to the control group (DMSO) ( < 0.01), and cell cycle arrest occurred at the G0/G1 phase. When challenged C57 BL/6J mice were treated with [Cu(PMPPSAL)(EtOH)], a smaller volume of B16 solid tumors were reported than the control group ( < 0.01), with lower positive expression indices of CD 34, vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) ( < 0.01). Moreover, the tumor growth was suppressed in mice due to the induction of apoptosis, as detected by the TUNEL assay ( < 0.001). In summary, [Cu(PMPP-SAL)(EtOH)] effectively inhibited the growth of B16 cells and due to the induction of apoptosis and the inhibition of intra-tumoral angiogenesis, demonstrating its therapeutic potential in melanoma treatment.
Pyrazolone-based derivative metal complexes were reported to have cytotoxicity in some tumor cells. In this study, the antitumor effect of [Cu(PMPP-SAL)(EtOH)] (PMPP-SAL = N -(1-phenyl-3-methyl-4-propenylidene-5-pyrazolone)- salicylidene hydrazide anion) in murine melanoma B16 cells in vitro and in vivo was investigated. The results showed that [Cu(PMPP-SAL)(EtOH)] inhibited the survival of B16 cells in vitro , and the IC 50 value was superior to cisplatin (DDP) ( p < 0.001). B16 cell apoptosis was significantly higher in comparison to the control group (DMSO) ( p < 0.01), and cell cycle arrest occurred at the G0/G1 phase. When challenged C57 BL/6J mice were treated with [Cu(PMPPSAL)(EtOH)], a smaller volume of B16 solid tumors were reported than the control group ( p < 0.01), with lower positive expression indices of CD 34, vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) ( p < 0.01). Moreover, the tumor growth was suppressed in mice due to the induction of apoptosis, as detected by the TUNEL assay ( p < 0.001). In summary, [Cu(PMPP-SAL)(EtOH)] effectively inhibited the growth of B16 cells in vitro and in vivo due to the induction of apoptosis and the inhibition of intra-tumoral angiogenesis, demonstrating its therapeutic potential in melanoma treatment.
Author Sun, Surong
Abula, Ayipairi
Li, Yijie
Xu, Guancheng
Zhao, Jing
Author_xml – sequence: 1
  givenname: Ayipairi
  surname: Abula
  fullname: Abula, Ayipairi
  organization: Xinjiang Key Laboratory of Biological Resources and Genetic Engineering College of Life Science and Technology Xinjiang University, Urumqi 830046 PR China
– sequence: 2
  givenname: Jing
  surname: Zhao
  fullname: Zhao, Jing
  organization: People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830046 PR China
– sequence: 3
  givenname: Guancheng
  surname: Xu
  fullname: Xu, Guancheng
  organization: Institute of Applied Chemistry, Xinjiang University, Urumqi 830046 PR China
– sequence: 4
  givenname: Yijie
  surname: Li
  fullname: Li, Yijie
  organization: Xinjiang Key Laboratory of Biological Resources and Genetic Engineering College of Life Science and Technology Xinjiang University, Urumqi 830046 PR China
– sequence: 5
  givenname: Surong
  surname: Sun
  fullname: Sun, Surong
  email: sunsrxju@xju.edu.cn
  organization: Xinjiang Key Laboratory of Biological Resources and Genetic Engineering College of Life Science and Technology Xinjiang University, Urumqi 830046 PR China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32412431$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1v1DAQxS1URD_gyhFZ4tIeUmzHsROJy7JqaaVFXYneELImzmTxKomD4xS2fz1ZUgpCcPKz9XtvRn7H5KDzHRLykrNzIXX-Bmz_JRFMsIQxyZ6QI55LlRRZlh_8oQ_J8TBsJ0LrXDwjh6mQXMiUH5Hdoosujq0PFOsabaS-pkD7XYB730yzkhIGrBLr277B7_TTcjxdf1ivk4-L1dnpRby5OvtMYQOuGyJtx-A6pC020PkW6DuuqMWmoa6jdy4GT6Gr5sudf06e1tAM-OLhPCG3lxe3y6tkdfP-erlYJVbKIiaYF7qsUHKZ1qi0nLRAoVVasbyQutIF1qzWvAKhCrCl1lDotJSMoa6lSk_I9RxbediaPrgWws54cObngw8bAyE626CRVqDK0aYoUsmLrARdK8a0ZTkvsSinrNdzVh_81xGHaLZ-DN20vRGSpUJlqmAT9eqBGssWq8eZvz59As5nwAY_DAHrR4Qzs2_V7Fs1-1bNvtXJIP8yWBchOt_FAK75v-3tbPsGTcRQ4SaMu0n83vrfRs1kpnj6A6ZpuB8
CitedBy_id crossref_primary_10_1016_j_jinorgbio_2022_111820
crossref_primary_10_1016_j_xphs_2025_103971
crossref_primary_10_1080_17425247_2023_2200997
Cites_doi 10.1016/j.cbpa.2007.11.013
10.3748/wjg.v11.i23.3544
10.21037/atm.2016.06.32
10.2174/0929867324666170414163937
10.1016/j.cbi.2014.10.012
10.1016/j.jinorgbio.2014.06.007
10.1016/j.ijbiomac.2017.09.043
10.1016/j.jinorgbio.2006.07.014
10.2152/jmi.51.202
10.1124/jpet.111.183681
10.1111/j.1529-8019.2005.00052.x
10.1038/sj.onc.1206454
10.1016/j.jinorgbio.2011.07.021
10.2174/1874357901711010028
10.3748/wjg.v13.i2.310
10.1021/cr068207j
10.1016/j.canlet.2006.09.008
10.1016/j.ejmech.2016.02.055
10.1158/0008-5472.CAN-05-4529
10.1002/chem.201404090
10.1016/j.poly.2007.08.045
10.1016/j.cbi.2015.02.004
ContentType Journal Article
Copyright 2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/3.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/3.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
BYOGL
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7N
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
DOA
DOI 10.2478/acph-2020-0040
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
East Europe, Central Europe Database
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
East Europe, Central Europe Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
DatabaseTitleList

Publicly Available Content Database
MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Open Access Full Text
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BYOGL
  name: East Europe, Central Europe Database
  url: https://search.proquest.com/eastcentraleurope
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1846-9558
EndPage 575
ExternalDocumentID oai_doaj_org_article_4c2e68ec3e234195ba7f6007c081be9b
32412431
10_2478_acph_2020_0040
10_2478_acph_2020_0040704561
Genre Journal Article
GroupedDBID ---
0R~
23M
2WC
4.4
5GY
5VS
7X7
88E
8AO
8FE
8FH
8FI
8FJ
9WM
AATOW
ABFKT
ABUWG
ACGFO
ACGFS
ACPRK
ADBBV
ADBLJ
AEGXH
AENEX
AFFHD
AFKRA
AFRAH
AHGSO
AIAGR
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
BYOGL
CCPQU
CS3
DIK
E0C
EBS
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HZ~
KQ8
LK8
M1P
M7P
O9-
OK1
OVT
P2P
P6G
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
QD8
RNS
SA.
SLJYH
TR2
UKHRP
VP8
AAYXX
CITATION
3V.
ALIPV
CGR
CUY
CVF
ECM
EIF
M~E
NPM
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
M7N
PKEHL
PQEST
PQUKI
ID FETCH-LOGICAL-c449t-e897bde4143fe674bde2e2763d08947d79ef0f71da269acb77a973b400e7f463
IEDL.DBID M7P
ISICitedReferencesCount 3
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000535907700010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1846-9558
1330-0075
IngestDate Mon Nov 10 04:34:47 EST 2025
Sun Oct 19 01:31:15 EDT 2025
Thu Jan 02 22:53:18 EST 2025
Tue Nov 18 22:00:47 EST 2025
Sat Nov 29 06:08:21 EST 2025
Sat Nov 29 01:30:54 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords tumor microangiogenesis
apoptosis
malignant melanoma
Cu(PMPP-SAL)(EtOH)
Language English
License This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
http://creativecommons.org/licenses/by-nc-nd/3.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c449t-e897bde4143fe674bde2e2763d08947d79ef0f71da269acb77a973b400e7f463
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
OpenAccessLink https://www.proquest.com/docview/2403265690?pq-origsite=%requestingapplication%
PMID 32412431
PQID 2403265690
PQPubID 2016342
PageCount 15
ParticipantIDs doaj_primary_oai_doaj_org_article_4c2e68ec3e234195ba7f6007c081be9b
proquest_journals_2403265690
pubmed_primary_32412431
crossref_primary_10_2478_acph_2020_0040
crossref_citationtrail_10_2478_acph_2020_0040
walterdegruyter_journals_10_2478_acph_2020_0040704561
PublicationCentury 2000
PublicationDate 2020-12-01
PublicationDateYYYYMMDD 2020-12-01
PublicationDate_xml – month: 12
  year: 2020
  text: 2020-12-01
  day: 01
PublicationDecade 2020
PublicationPlace Poland
PublicationPlace_xml – name: Poland
– name: Zagreb
PublicationTitle Acta pharmaceutica (Zagreb, Croatia)
PublicationTitleAlternate Acta Pharm
PublicationYear 2020
Publisher Sciendo
De Gruyter Brill Sp. z o.o., Paradigm Publishing Services
Publisher_xml – name: Sciendo
– name: De Gruyter Brill Sp. z o.o., Paradigm Publishing Services
References 2024041818160360906_j_acph-2020-0040_ref_016_w2aab3b7c17b1b6b1ab1ac16Aa
2024041818160360906_j_acph-2020-0040_ref_025_w2aab3b7c17b1b6b1ab1ac25Aa
2024041818160360906_j_acph-2020-0040_ref_012_w2aab3b7c17b1b6b1ab1ac12Aa
2024041818160360906_j_acph-2020-0040_ref_003_w2aab3b7c17b1b6b1ab1ab3Aa
2024041818160360906_j_acph-2020-0040_ref_008_w2aab3b7c17b1b6b1ab1ab8Aa
2024041818160360906_j_acph-2020-0040_ref_021_w2aab3b7c17b1b6b1ab1ac21Aa
2024041818160360906_j_acph-2020-0040_ref_019_w2aab3b7c17b1b6b1ab1ac19Aa
2024041818160360906_j_acph-2020-0040_ref_015_w2aab3b7c17b1b6b1ab1ac15Aa
2024041818160360906_j_acph-2020-0040_ref_007_w2aab3b7c17b1b6b1ab1ab7Aa
2024041818160360906_j_acph-2020-0040_ref_024_w2aab3b7c17b1b6b1ab1ac24Aa
2024041818160360906_j_acph-2020-0040_ref_011_w2aab3b7c17b1b6b1ab1ac11Aa
2024041818160360906_j_acph-2020-0040_ref_020_w2aab3b7c17b1b6b1ab1ac20Aa
2024041818160360906_j_acph-2020-0040_ref_004_w2aab3b7c17b1b6b1ab1ab4Aa
2024041818160360906_j_acph-2020-0040_ref_018_w2aab3b7c17b1b6b1ab1ac18Aa
2024041818160360906_j_acph-2020-0040_ref_001_w2aab3b7c17b1b6b1ab1ab1Aa
2024041818160360906_j_acph-2020-0040_ref_014_w2aab3b7c17b1b6b1ab1ac14Aa
2024041818160360906_j_acph-2020-0040_ref_023_w2aab3b7c17b1b6b1ab1ac23Aa
2024041818160360906_j_acph-2020-0040_ref_005_w2aab3b7c17b1b6b1ab1ab5Aa
2024041818160360906_j_acph-2020-0040_ref_010_w2aab3b7c17b1b6b1ab1ac10Aa
2024041818160360906_j_acph-2020-0040_ref_002_w2aab3b7c17b1b6b1ab1ab2Aa
2024041818160360906_j_acph-2020-0040_ref_017_w2aab3b7c17b1b6b1ab1ac17Aa
2024041818160360906_j_acph-2020-0040_ref_006_w2aab3b7c17b1b6b1ab1ab6Aa
2024041818160360906_j_acph-2020-0040_ref_013_w2aab3b7c17b1b6b1ab1ac13Aa
2024041818160360906_j_acph-2020-0040_ref_022_w2aab3b7c17b1b6b1ab1ac22Aa
2024041818160360906_j_acph-2020-0040_ref_009_w2aab3b7c17b1b6b1ab1ab9Aa
References_xml – ident: 2024041818160360906_j_acph-2020-0040_ref_005_w2aab3b7c17b1b6b1ab1ab5Aa
  doi: 10.1016/j.cbpa.2007.11.013
– ident: 2024041818160360906_j_acph-2020-0040_ref_018_w2aab3b7c17b1b6b1ab1ac18Aa
  doi: 10.3748/wjg.v11.i23.3544
– ident: 2024041818160360906_j_acph-2020-0040_ref_019_w2aab3b7c17b1b6b1ab1ac19Aa
– ident: 2024041818160360906_j_acph-2020-0040_ref_003_w2aab3b7c17b1b6b1ab1ab3Aa
  doi: 10.21037/atm.2016.06.32
– ident: 2024041818160360906_j_acph-2020-0040_ref_001_w2aab3b7c17b1b6b1ab1ab1Aa
  doi: 10.2174/0929867324666170414163937
– ident: 2024041818160360906_j_acph-2020-0040_ref_008_w2aab3b7c17b1b6b1ab1ab8Aa
  doi: 10.1016/j.cbi.2014.10.012
– ident: 2024041818160360906_j_acph-2020-0040_ref_010_w2aab3b7c17b1b6b1ab1ac10Aa
  doi: 10.1016/j.jinorgbio.2014.06.007
– ident: 2024041818160360906_j_acph-2020-0040_ref_015_w2aab3b7c17b1b6b1ab1ac15Aa
– ident: 2024041818160360906_j_acph-2020-0040_ref_025_w2aab3b7c17b1b6b1ab1ac25Aa
  doi: 10.1016/j.ijbiomac.2017.09.043
– ident: 2024041818160360906_j_acph-2020-0040_ref_023_w2aab3b7c17b1b6b1ab1ac23Aa
– ident: 2024041818160360906_j_acph-2020-0040_ref_011_w2aab3b7c17b1b6b1ab1ac11Aa
  doi: 10.1016/j.jinorgbio.2006.07.014
– ident: 2024041818160360906_j_acph-2020-0040_ref_024_w2aab3b7c17b1b6b1ab1ac24Aa
  doi: 10.2152/jmi.51.202
– ident: 2024041818160360906_j_acph-2020-0040_ref_021_w2aab3b7c17b1b6b1ab1ac21Aa
  doi: 10.1124/jpet.111.183681
– ident: 2024041818160360906_j_acph-2020-0040_ref_004_w2aab3b7c17b1b6b1ab1ab4Aa
  doi: 10.1111/j.1529-8019.2005.00052.x
– ident: 2024041818160360906_j_acph-2020-0040_ref_007_w2aab3b7c17b1b6b1ab1ab7Aa
  doi: 10.1038/sj.onc.1206454
– ident: 2024041818160360906_j_acph-2020-0040_ref_012_w2aab3b7c17b1b6b1ab1ac12Aa
  doi: 10.1016/j.jinorgbio.2011.07.021
– ident: 2024041818160360906_j_acph-2020-0040_ref_002_w2aab3b7c17b1b6b1ab1ab2Aa
  doi: 10.2174/1874357901711010028
– ident: 2024041818160360906_j_acph-2020-0040_ref_020_w2aab3b7c17b1b6b1ab1ac20Aa
  doi: 10.3748/wjg.v13.i2.310
– ident: 2024041818160360906_j_acph-2020-0040_ref_006_w2aab3b7c17b1b6b1ab1ab6Aa
  doi: 10.1021/cr068207j
– ident: 2024041818160360906_j_acph-2020-0040_ref_014_w2aab3b7c17b1b6b1ab1ac14Aa
  doi: 10.1016/j.canlet.2006.09.008
– ident: 2024041818160360906_j_acph-2020-0040_ref_013_w2aab3b7c17b1b6b1ab1ac13Aa
  doi: 10.1016/j.ejmech.2016.02.055
– ident: 2024041818160360906_j_acph-2020-0040_ref_022_w2aab3b7c17b1b6b1ab1ac22Aa
  doi: 10.1158/0008-5472.CAN-05-4529
– ident: 2024041818160360906_j_acph-2020-0040_ref_009_w2aab3b7c17b1b6b1ab1ab9Aa
  doi: 10.1002/chem.201404090
– ident: 2024041818160360906_j_acph-2020-0040_ref_016_w2aab3b7c17b1b6b1ab1ac16Aa
  doi: 10.1016/j.poly.2007.08.045
– ident: 2024041818160360906_j_acph-2020-0040_ref_017_w2aab3b7c17b1b6b1ab1ac17Aa
  doi: 10.1016/j.cbi.2015.02.004
SSID ssj0047782
Score 2.2563255
Snippet Pyrazolone-based derivative metal complexes were reported to have cytotoxicity in some tumor cells. In this study, the antitumor effect of [Cu(PMPP-SAL)(EtOH)]...
SourceID doaj
proquest
pubmed
crossref
walterdegruyter
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 561
SubjectTerms Angiogenesis
Angiogenesis Inhibitors - pharmacology
Animals
Antigens, CD34 - biosynthesis
Antineoplastic Agents - pharmacology
Antitumor activity
Apoptosis
Cadmium
Cell cycle
Cell Survival - drug effects
Cisplatin
Cisplatin - pharmacology
Copper
Cu(PMPP-SAL)(EtOH)
Cytotoxicity
Drug Screening Assays, Antitumor
Fibroblast growth factor 2
G1 phase
Growth factors
malignant melanoma
Melanoma
Melanoma, Experimental - drug therapy
Mice
Mice, Inbred C57BL
Pyrazolones - pharmacology
Solid tumors
Tumor cells
tumor microangiogenesis
Vascular endothelial growth factor
Vascular Endothelial Growth Factor A - biosynthesis
Xenograft Model Antitumor Assays
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYl9NAeQt_dNi06lDSBiOzKWss6bkJCDm1q6B4CpRi9nCxk7cXr3db99Z2R9hFKSi-9GNuM8OAZzXx6fUPIB5M4B0jZs5S7jAljLDNDJxiMl2W_D41KZ0OxCXl5mV1dqfxOqS_cExbpgeOPOxaW-zTzNvEcqceGRssSOdUt5DLjlcHoC6hnPZiKMVhISHyRopELmR1rO7sBf-B4iBqnOe6koMDUfx-8fEx2f4QVa-evm0XXrldIQ-I5f0J2V4iRjqKmT8kDXz0j-3mknO6O6Hh7gmp-RPdpviWj7p6TboTncBfTuqFx6watS6rprGv0LxCpPMM85ljYWu5_0m-ni4P8c56zr6NPhwdn7ZeLw-9UX-sJwEg6xal5T6f-Vlf1VNOTQUpx5p9OKrqctE1NdeXiw7J-QcbnZ-PTC7Yqt8CsEKplPlPSOC8AQZU-lQLuuecQf8CYYDknlS_7pRw4zVOlrZFSK5kYCAJeliJNXpKdCtR-Tah1_VIlbshLpcK6q0t9lhq4eoxnqkfY2gCFXVGRY0WM2wKGJGiwAg1WoMEKNFiPfNzIzyIJx18lT9CeGykkzw4vwKWKlUsV_3KpHtlbe0Ox6tHzAnkLOYBfBd94FT1k8xUApQCTkkGPDP9wmW37-_WViKgHb_6H1m_Jo-DhYavNHtlpm4V_Rx7aZTuZN-9D9_gNRP0UKw
  priority: 102
  providerName: Directory of Open Access Journals
Title Antitumor effect of a pyrazolone-based-complex [Cu(PMPP-SAL)(EtOH)] against murine melanoma B16 cell in vitro and in vivo
URI https://reference-global.com/article/10.2478/acph-2020-0040
https://www.ncbi.nlm.nih.gov/pubmed/32412431
https://www.proquest.com/docview/2403265690
https://doaj.org/article/4c2e68ec3e234195ba7f6007c081be9b
Volume 70
WOSCitedRecordID wos000535907700010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Open Access Full Text
  customDbUrl:
  eissn: 1846-9558
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0047782
  issn: 1846-9558
  databaseCode: DOA
  dateStart: 20070101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1846-9558
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0047782
  issn: 1846-9558
  databaseCode: M7P
  dateStart: 20070301
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: East Europe, Central Europe Database
  customDbUrl:
  eissn: 1846-9558
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0047782
  issn: 1846-9558
  databaseCode: BYOGL
  dateStart: 20070301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/eastcentraleurope
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1846-9558
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0047782
  issn: 1846-9558
  databaseCode: 7X7
  dateStart: 20070301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1846-9558
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0047782
  issn: 1846-9558
  databaseCode: BENPR
  dateStart: 20070301
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Publicly Available Content
  customDbUrl:
  eissn: 1846-9558
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0047782
  issn: 1846-9558
  databaseCode: PIMPY
  dateStart: 20070301
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9NAEF3RlgMcyjcNlGgPqLRSV01sx-s9oaRKVSQaLMghCCFrvxwiNXbqOIHw65lZOwlChQuXKHHWsq15nn07M_uGkNfKNwaYsmWhZyIWKKWZ6piAwXqZt1pwUmq0azbBB4NoNBJxHXCb12WVa5_oHLXJNcbIz1A3zgPyIVpvZzcMu0ZhdrVuobFD9lAlwXele_HaEwecu2ZRsAzD3dO8U4k2egGPzqSefQOEePgHBj5-m5Scdv9thPM-2f_uctjGjovFqlznTN1UdPHgfx_iIdmvSSjtVqh5RO7Y7DE5iisV69UpHW43Zc1P6RGNt_rWqydk1cWtvYtpXtCqGoTmKZV0tirkTxiSWYZTo2GuWt3-oF_OF8fxVRyzT933J8f98sPlyVcqx3ICzJROMdpv6dReyyyfStprhxSTCXSS0eWkLHIqM1P9WOZPyfCiPzy_ZHUHB6aDQJTMRoIrYwMgZakNeQDfPeuBSwN8ABgMFzZtpbxtpBcKqRXnUnBfgV-xPA1C_xnZzeC2DwjVppUK33S8VAiXyjWhjUIFnxZdpGgQtrZgomt1c2yycZ3AKgctnqDFE7R4ghZvkDeb8bNK1-OvI3sIiM0o1ON2B_JinNSvdxJoz4aR1b71UCCvoyRPUflfA-NSVqgGOVwDIqmdxDzZoqFBnlcQ21wFeC4wL7_dIJ0_MLc9__b75UjS2y_-fcGX5J4Dv6vLOSS7ZbGwr8hdvSwn86JJdviIN8lerz-IPzZdmKLp3iw4Fr-7ij__ApvSKRo
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3Nb9MwFLfGQAIO4xsKA3yAsUmz1jppHB8Q6samTutKJHqYNCHLsZ1SaU1KmnaE_4n_kWenaREa3HbgEuXDiS3n5-ff83t-D6E3sac1MGVDAqpD4sexInFb-wT0ZdZswkuJVi7ZBOv3w7MzHq2hn_VeGOtWWctEJ6h1puwa-Z6NG0eBfPDmh8k3YrNGWetqnUKjgsWJKS9BZZu-P_4I__ctpUeHg4MuWWQVIMr3eUFMyFmsjQ9EITEB8-GcGgrDDNoMDdSMm6SZsJaWNOBSxYxJzrwYsG5Y4gcefPYGugksgobOUzCqBb_PmMtNBVqf3azN2lWMSOqzcE-qyVcAJLUP7DrLb3OgSxVwFb-9izYunclcm2E-K4vaROtmvqN7_1mf3UcbC4qNO9WYeIDWTPoQbUVVjO5yFw9WW86mu3gLR6vo3eUjVHbsxuXZOMtx5euCswRLPClz-QOKpIbYiV8T54tvvuPzg9l2dBpF5HOnt7N9WHzq7nzBcihHwLvx2NoyDB6bC5lmY4n3WwG2phI8SvF8VOQZlqmuLubZYzS4jl55gtZTaPYzhJVuJtzTbZpw7gzVOjBhEMPR2AmANxCpASPUIna7TSFyIUCHswATFmDCAkxYgDXQu2X5SRW15K8l9y3-lqVstHF3I8uHYiG8hK-oCUKjPENt-L92LFli8xoo4JOx4XEDbdb4EwsROBUr8DXQ0wrRy1qAxQOv9FoN1P4D4qv3r24vsypI6_m_K3yNbncHpz3RO-6fvEB33LhzHkibaL3IZ-YluqXmxWiav3IDGCNxzeD_BerTgGI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antitumor+effect+of+a+pyrazolone-based-complex+%5BCu%28PMPP-SAL%29%28EtOH%29%5D+against+murine+melanoma+B16+cell+in+vitro+and+in+vivo&rft.jtitle=Acta+pharmaceutica+%28Zagreb%2C+Croatia%29&rft.au=Abula%2C+Ayipairi&rft.au=Zhao%2C+Jing&rft.au=Xu%2C+Guancheng&rft.au=Li%2C+Yijie&rft.date=2020-12-01&rft.pub=De+Gruyter+Brill+Sp.+z+o.o.%2C+Paradigm+Publishing+Services&rft.issn=1330-0075&rft.eissn=1846-9558&rft.volume=70&rft.issue=4&rft.spage=561&rft.epage=575&rft_id=info:doi/10.2478%2Facph-2020-0040
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1846-9558&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1846-9558&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1846-9558&client=summon